Fresenius Medical Care AG & Co. KGaA ADR logo

Fresenius Medical Care AG & Co. KGaA ADR (FMS)

Market Closed
12 Dec, 20:00
NYSE NYSE
$
23. 58
+0.2
+0.86%
$
13.96B Market Cap
20.41 P/E Ratio
4.87% Div Yield
212,501 Volume
0 Eps
$ 23.38
Previous Close
Day Range
23.37 23.58
Year Range
22.05 30.46
Want to track FMS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 72 days
Here's Why Fresenius (FMS) is a Strong Value Stock

Here's Why Fresenius (FMS) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 6 months ago
Fresenius (FMS) is a Great Momentum Stock: Should You Buy?

Fresenius (FMS) is a Great Momentum Stock: Should You Buy?

Does Fresenius (FMS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 7 months ago
Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?

Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 7 months ago
Best Income Stocks to Buy for May 9th

Best Income Stocks to Buy for May 9th

SSUMY and FMS made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 9, 2025.

Zacks | 7 months ago
FMS Stock Up as Q1 Earnings Beat Estimates, Revenues Up Y/Y

FMS Stock Up as Q1 Earnings Beat Estimates, Revenues Up Y/Y

Fresenius Medical's first-quarter results showcase a strong segmental performance, along with reiterating its 2025 outlook for revenue growth.

Zacks | 7 months ago
Why Fresenius (FMS) is a Top Value Stock for the Long-Term

Why Fresenius (FMS) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 7 months ago
Fresenius Medical Care tops market expectations in 1st quarter

Fresenius Medical Care tops market expectations in 1st quarter

World's largest dialysis specialist Fresenius Medical Care reported first-quarter results above analysts' expectations on Tuesday, as revenue grew organically in all its segments, it said.

Reuters | 7 months ago
Should You Buy, Sell, or Hold FMS Stock Before Q1 Earnings?

Should You Buy, Sell, or Hold FMS Stock Before Q1 Earnings?

Fresenius Medical Care heads into the first quarter of 2025 with momentum from cost savings, innovation like the 5008X launch, and a steady recovery in U.S. treatment volumes.

Zacks | 7 months ago
Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?

Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 7 months ago
Here's Why Fresenius (FMS) is a Strong Value Stock

Here's Why Fresenius (FMS) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 8 months ago
Why Fresenius Medical Care Stock Might be a Great Pick

Why Fresenius Medical Care Stock Might be a Great Pick

FMS has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Zacks | 8 months ago
Here's Why Fresenius (FMS) is a Strong Momentum Stock

Here's Why Fresenius (FMS) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 8 months ago
Loading...
Load More